Quick Answer
Boundless Bio, Inc. reported Net Income Loss of -$58.20 million for the year ending 2025.
- Boundless Bio, Inc. showed an increase of +11.0% in Net Income Loss from 2024 to 2025.
- This data is from Boundless Bio, Inc.'s annual report (Form 10-K), filed with the SEC on March 9, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), Boundless Bio, Inc.'s Net Income Loss has declined by 17.7%.
- Historical annual values: Fiscal year 2025: -$58.20 million | Fiscal year 2024: -$65.36 million | Fiscal year 2023: -$49.43 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: